Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Systematic Meta-analysis
100%
Meta-analysis
100%
Squamous Cell Carcinoma (SqCC)
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Survival Outcomes
100%
Hazard Ratio
54%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
54%
Overall Survival
45%
Non-oropharyngeal
36%
Tumor
18%
Disease-free Survival
18%
Randomized Clinical Trial
18%
Oral Cavity
18%
Disease-specific Survival
18%
Hypopharyngeal
18%
Clinical Trials
9%
English Language
9%
Working Diagnosis
9%
Non-associated
9%
Selection Analysis
9%
Survival Impact
9%
Distant Metastasis
9%
Clinical Follow-up
9%
PubMed
9%
Data Extraction
9%
Data Synthesis
9%
Nasopharynx
9%
Metastatic Tumor
9%
Random Effects Model
9%
Nasopharyngeal
9%
Reporting Item
9%
Embase
9%
Risk of Bias
9%
Clinical Observational Study
9%
CINAHL
9%
Newcastle-Ottawa Scale
9%
Laryngeal Tumor
9%
Cavity Location
9%
Pharyngeal Tumor
9%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Squamous Cell Carcinoma
100%
Wart Virus
100%
Hazard Ratio
54%
Oropharynx Squamous Cell Carcinoma
54%
Overall Survival
45%
Disease Free Survival
18%
Oral Cavity
18%
Disease Specific Survival
18%
Tumor
18%
Randomized Clinical Trials
18%
Cancer
9%
English (Language)
9%
Clinical Study
9%
Metastatic Carcinoma
9%
Prognostication
9%
Observational Study
9%
Nasopharynx
9%
Random Effects Model
9%
Larynx Tumor
9%
Hypopharynx Tumor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Human Papillomavirus
100%
Oropharynx Squamous Cell Carcinoma
54%
Overall Survival
45%
Randomized Clinical Trial
18%
Disease Specific Survival
18%
Disease Free Survival
18%
Clinical Study
9%
Observational Study
9%
Random Effects Model
9%
Larynx Tumor
9%
Hypopharynx Tumor
9%